Literature DB >> 21880749

Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4.

Christian St-Pierre1, Hiroshi Manya, Michel Ouellet, Gary F Clark, Tamao Endo, Michel J Tremblay, Sachiko Sato.   

Abstract

Sexual transmission of HIV-1 requires virus adsorption to a target cell, typically a CD4(+) T lymphocyte residing in the lamina propria, beneath the epithelium. To escape the mucosal clearance system and reach its target cells, HIV-1 has evolved strategies to circumvent deleterious host factors. Galectin-1, a soluble lectin found in the underlayers of the epithelium, increases HIV-1 infectivity by accelerating its binding to susceptible cells. By comparison, galectin-3, a family member expressed by epithelial cells and part of the mucosal clearance system, does not perform similarly. We show here that galectin-1 directly binds to HIV-1 in a β-galactoside-dependent fashion through recognition of clusters of N-linked glycans on the viral envelope gp120. Unexpectedly, this preferential binding of galectin-1 does not rely on the primary sequence of any particular glycans. Instead, glycan clustering arising from the tertiary structure of gp120 hinders its binding by galectin-3. Increased polyvalency of a specific ligand epitope is a common strategy for glycans to increase their avidity for lectins. In this peculiar occurrence, glycan clustering is instead exploited to prevent binding of gp120 by galectin-3, which would lead to a biological dead-end for the virus. Our data also suggest that galectin-1 binds preferentially to CD4, the host receptor for gp120. Together, these results suggest that HIV-1 exploits galectin-1 to enhance gp120-CD4 interactions, thereby promoting virus attachment and infection events. Since viral adhesion is a rate-limiting step for HIV-1 entry, modulation of the gp120 interaction with galectin-1 could thus represent a novel approach for the prevention of HIV-1 transmission.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880749      PMCID: PMC3209312          DOI: 10.1128/JVI.05351-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Comparative study of the asparagine-linked sugar chains of human lipocalin-type prostaglandin D synthase purified from urine and amniotic fluid, and recombinantly expressed in Chinese hamster ovary cells.

Authors:  H Manya; Y Sato; N Eguchi; K Seiki; H Oda; H Nakajima; Y Urade; T Endo
Journal:  J Biochem       Date:  2000-06       Impact factor: 3.387

Review 2.  Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Authors:  Sachiko Sato; Julie Nieminen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 3.  Inhibiting sexual transmission of HIV-1 infection.

Authors:  Robin J Shattock; John P Moore
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

4.  Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.

Authors:  Katie J Doores; Camille Bonomelli; David J Harvey; Snezana Vasiljevic; Raymond A Dwek; Dennis R Burton; Max Crispin; Christopher N Scanlan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

5.  Three soluble rat beta-galactoside-binding lectins.

Authors:  R F Cerra; M A Gitt; S H Barondes
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

6.  DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection.

Authors:  Douglas S Kwon; Glenn Gregorio; Natacha Bitton; Wayne A Hendrickson; Dan R Littman
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

Review 7.  The CD4 antigen: physiological ligand and HIV receptor.

Authors:  Q J Sattentau; R A Weiss
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

8.  Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.

Authors:  H Feinberg; D A Mitchell; K Drickamer; W I Weis
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

9.  Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material.

Authors:  Mélanie R Tardif; Michel J Tremblay
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  50 in total

1.  Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages.

Authors:  Jessica L Reynolds; Wing Cheung Law; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Ken-Tye Yong; Rui Hui; Paras N Prasad; Stanley A Schwartz
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-12       Impact factor: 4.147

2.  Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.

Authors:  Christian St-Pierre; Michel Ouellet; Denis Giguère; Reiko Ohtake; René Roy; Sachiko Sato; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Structural basis of redox-dependent modulation of galectin-1 dynamics and function.

Authors:  Carlos M Guardia; Julio J Caramelo; Madia Trujillo; Santiago P Méndez-Huergo; Rafael Radi; Darío A Estrin; Gabriel A Rabinovich
Journal:  Glycobiology       Date:  2014-01-21       Impact factor: 4.313

4.  A chimeric, multivalent assembly of galectin-1 and galectin-3 with enhanced extracellular activity.

Authors:  Margaret M Fettis; Shaheen A Farhadi; Gregory A Hudalla
Journal:  Biomater Sci       Date:  2019-04-23       Impact factor: 6.843

Review 5.  Evolving mechanistic insights into galectin functions.

Authors:  Connie M Arthur; Marcelo Dias Baruffi; Richard D Cummings; Sean R Stowell
Journal:  Methods Mol Biol       Date:  2015

6.  Restriction of Human Cytomegalovirus Infection by Galectin-9.

Authors:  Allison Abendroth; Brian P McSharry; Barry Slobedman; Emily A Machala; Selmir Avdic; Lauren Stern; Dirk M Zajonc; Chris A Benedict; Emily Blyth; David J Gottlieb
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

7.  Self-assembled glycopeptide nanofibers as modulators of galectin-1 bioactivity.

Authors:  Antonietta Restuccia; Ye F Tian; Joel H Collier; Gregory A Hudalla
Journal:  Cell Mol Bioeng       Date:  2015-06-15       Impact factor: 2.321

Review 8.  Innate immunity against molecular mimicry: Examining galectin-mediated antimicrobial activity.

Authors:  Connie M Arthur; Seema R Patel; Amanda Mener; Nourine A Kamili; Ross M Fasano; Erin Meyer; Annie M Winkler; Martha Sola-Visner; Cassandra D Josephson; Sean R Stowell
Journal:  Bioessays       Date:  2015-12       Impact factor: 4.345

9.  Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes.

Authors:  A M Woodward; J Mauris; P Argüeso
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

10.  Galectin-3 promotes HIV-1 budding via association with Alix and Gag p6.

Authors:  Sheng-Fan Wang; Ching-Han Tsao; Yu-Ting Lin; Daniel K Hsu; Meng-Lin Chiang; Chia-Hui Lo; Fan-Ching Chien; Peilin Chen; Yi-Ming Arthur Chen; Huan-Yuan Chen; Fu-Tong Liu
Journal:  Glycobiology       Date:  2014-07-04       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.